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2Abstract 
Incidence of cutaneous malignant melanoma has continued to rise despite public efforts 
to promote sun protection behaviors among populations at risk. However, dietary factors may 
also affect the development of melanoma. In the past few decades, findings from 
epidemiological and experimental research have linked consumption of several foods and other 
nutrients to the risk of melanoma. Caffeine has been associated with a lower risk of melanoma, 
and citrus fruits and alcohol with increased risk. Associations between polyunsaturated fatty acid, 
niacin/nicotinamide, folate and Vitamin D with melanoma remain controversial. Diet likely 
influences melanoma development through several potential mechanisms, such as enhancing 
UV-induced apoptosis and increasing photosensitivity. We conducted a narrative review to 
summarize recent epidemiological studies of diet and melanoma based on published literature. 
Given the high prevalence of the food items and nutrients covered in this review and the 
decades-long rising melanoma incidence worldwide, the associations we discuss may have 
important public health implications in terms of reducing melanoma incidence through dietary 
modification.  
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3Introduction 
Cutaneous malignant melanoma is the fifth most common cancer in the United States and 
one of the deadliest forms of skin cancer because of its high metastatic potential (1). The U.S. is 
estimated to have 91,270 new melanoma cases in 2018, which will account for approximately 
5.3% of all new cancers; the number of deaths from melanoma in 2018 is estimated at 9,320, or 
approximately 1.5% of all cancer deaths. Incidence rates for new melanoma cases have been 
rising an average of 1.5% per year over the past decade; mortality rates have been falling on 
average 1.2% per year during 2006-2015; and the five-year survival rate has climbed from 81.8% 
in 1975-1977 to 91.8% in 2008-2014 (1). 
Excess exposure to ultraviolet radiation (UVR) from natural sunlight or tanning devices 
is the most important risk factor for melanoma. Other common risk factors include family history 
of melanoma, number of atypical moles, history of severe sunburns, as well as phenotypic 
characteristics such as low tanning ability, light skin, light eye color, and red/blonde hair (2). 
Animal studies have shown promising results supporting the role of some natural compounds in 
the chemoprevention of melanoma. Epidemiological studies have also suggested that some 
dietary factors and nutrients might play roles in affecting melanoma risk (3), though the 
significance of many of those associations is still controversial. Diet likely influences melanoma 
development through several potential mechanisms, such as lowering melanoma risk by 
enhancing UV-induced apoptosis (4) and increasing melanoma risk by enhancing 
photosensitivity (5). 
A few reviews of diet and melanoma have been published; however, most have focused 
specifically on some natural compounds of the diet with antioxidant properties, such as vitamins 
A, C, and E, and selenium (3,6-8). Herein, in this paper, we provide a comprehensive review of 
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paper includes a list of updated references and a large coverage of dietary factors that may have a 
role in melanoma, including coffee and caffeine, citrus fruits, alcohol, polyunsaturated fatty acid, 
niacin/nicotinamide, folate, and vitamin D. Additionally, we also discussed the underlying 
biological mechanisms and outlined some possible future directions in the field. Since some 
dietary factors emerged as promising candidates for chemoprevention, through summarizing 
current evidence, we also hope our review could encourage further efforts in both research and 
practice in this field.  
Methods 
We conducted a narrative review based on literature published in English (up to January 
2018). Relevant articles were identified by searching the keywords “diet melanoma”, “nutrition 
melanoma”, “melanoma chemoprevention”, “coffee melanoma”, “citrus melanoma”, “alcohol 
melanoma”, “niacin melanoma”, “nicotinamide melanoma”, “fatty acid melanoma”, “folate 
melanoma”, and “vitamin D melanoma” in PubMed.  
Diet and cutaneous malignant melanoma 
1. Coffee and caffeine
Coffee is quite widely consumed. Animal studies have shown that caffeine may inhibit 
UV-induced sunburn lesions in the epidermis of mice and may mimic the effect of a sunscreen 
(4). Though caffeinated coffee is the major source of caffeine, other foods high in caffeine 
include tea, cola, and chocolate. Epidemiologic evidence for the association between coffee 
consumption and risk of melanoma has been ambiguous. Some studies suggested an inverse 
association (9,10), whereas others showed no significant association (11-13); though the latter 
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Most evidence on this topic comes from cohort studies. Data from the Norwegian 
Women and Cancer (NOWAC) Study (1.7 million person-years of follow-up) showed reduced 
melanoma risk associated with a moderate intake of filtered coffee but not with instant, boiled, or 
total coffee consumption (14). Song et al. (11) analyzed pooled data from the Nurses’ Health 
Study (NHS) (24 years of follow-up from 1984) and the Health Professionals Follow-up Study 
(HPFS) (22 years of follow-up from 1986); they found that neither caffeinated nor decaffeinated 
coffee—nor even total caffeine intake from all dietary sources—was significantly associated 
with melanoma risk. However, NHS and HPFS used different cutoffs for caffeine intake levels, 
which may have produced heterogeneity in the estimates of higher-intake groups versus 
reference groups over the total study populations (15). Therefore, Wu et al. further regrouped 
participants from the NHS (1980-2008) and the HPFS (1986-2008) using caffeine intake 
quintiles in the Nurses’ Health Study II (NHS II) (1991-2009) (15). They found that melanoma 
risk among those with higher caffeine intake (≥393 mg/day) was significantly lower than among 
those with lower caffeine intake (<60 mg/day) [HR (95% CI)=0.78 (0.64-0.96)]. Among women, 
caffeinated coffee consumption was significantly associated with lower melanoma risk [>2/Day 
vs. never: HR (95% CI)=0.76 (0.64-0.89)], though the association between decaffeinated coffee 
consumption and melanoma risk was not significant. Moreover, Wu et al. (15) also found that 
the inverse association between caffeine and melanoma was significant for melanoma on the 
head, neck, and extremities [≥393 mg/day vs. <60 mg/day: HR (95% CI) = 0.71 (0.59-0.86)] but 
insignificant for melanoma on the trunk, including shoulder, back, hip, abdomen, and chest 
[≥393 mg/day vs. <60 mg/day: HR (95% CI) = 0.90 (0.70-1.20)].  
In addition, after a median follow-up of 10.5 years among 447,357 non-Hispanic white 
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decrease in melanoma risk among people with higher coffee intake [≥4 cups/day vs. None: HR 
(95% CI) = 0.80 (0.68-0.93)]; the association was significant for caffeinated [≥4 cups/day vs. 
None: HR (95% CI) = 0.75 (0.64-0.89)] but not for decaffeinated coffee. Similarly, Caini et al. 
(17) reported an inverse association between caffeinated coffee consumption and melanoma risk
among men [4th quartile vs. none: HR (95% CI) = 0.31 (0.14-0.69)], but not in women, and no 
association with decaffeinated coffee consumption among either men or women, after a median 
follow-up of 14.9 years among 476,160 participants in the European Prospective Investigation 
into Cancer and Nutrition (EPIC) study. The associations reported in these cohort studies were 
adjusted for age, sex, body mass index (BMI), potential lifestyle confounders such as physical 
activity, smoking, and alcohol consumption, as well as known melanoma risk factors (11,15-17). 
Finally, significant inverse associations between caffeinated coffee and melanoma were also 
reported by two recent meta-analyses of observational studies (18,19).  
Taken together, current epidemiological evidence suggests that higher caffeine intake and 
caffeinated coffee consumption may help reduce melanoma risk. Evidence from biomedical 
research lends biological plausibility to the possible beneficial role of caffeine intake in 
protecting against UVB-induced carcinogenesis. Animal studies have demonstrated that oral 
administration of caffeine may eliminate sunburned cells by enhancing UV-induced apoptosis, 
thus preventing UV-induced carcinogenesis (4,20). Further, research indicated that the ability of 
caffeine to promote the apoptosis of DNA-damaged cells could be related to the inhibition of the 
ataxia telangiectasia and Rad3-related (ATR) kinase or its downstream target checkpoint kinase 
1 (Chk1) (ATR/Chk1 pathway) (21,22). It has been shown that irradiation of mouse skin with 
UVB activated the ATR/Chk1 pathways, induced phosphorylation of Chk1 on Ser345, and further 
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enhanced the removal of DNA-damaged cells by inhibiting the ATR-mediated phosphorylation 
of Chk1 and abrogating the UVB-induced decrease in mitotic cells with cyclin B1 (22,23). 
Moreover, considering the biological evidence for caffeine’s beneficial effect against UV-
induced skin cancer (24) and the hypothesis that the role of sunlight in melanoma differs 
according to anatomic site (25), it is plausible that caffeine may have a stronger beneficial effect 
in reducing risk of sun-induced cutaneous carcinogenesis on body sites receiving higher 
continuous UV radiation (e.g., head, neck) compared with body sites receiving lower continuous 
UV radiation (e.g., trunk); this was observed in Wu et al.’s study (15).  
2. Citrus fruit
A limited number of epidemiological studies have examined the relationship between 
citrus fruit consumption and melanoma. In 2003, Feskanich et al. (26) reported an unexpected 
higher risk among the NHS (1984-1998) and NHS II (1991-1999) cohorts of US women who 
consumed more orange juice and derived vitamin C from foods, but not from supplements; 
compared to no orange juice consumption, consumption ≥ 1 serving per day was associated with 
an elevated risk of melanoma [RR=1.61, 95% CI=0.92-2.84, P for linear trend=0.008]. Since 
vitamin C has preferential toxicity for melanoma cells (26), the increased melanoma risk 
associated with dietary vitamin C was likely the effect of other components (e.g., photoactive 
compounds such as psoralens and furocoumarins (5), a group of naturally occurring chemicals 
that, through sensitizing the skin to UV radiation, may have photocarcinogenic properties) in 
vitamin C–rich foods (e.g., citrus fruits).  
Using data from the NHS (1984-2010) and HPFS (1986-2010) cohorts, Wu et al. (5) 
found that citrus consumption was associated with increased risk of melanoma, and the 
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frequency of exposure in their pooled analysis; consumption of citrus fruits ≥ 1.6 times per day 
was associated with higher risk for developing melanoma compared to consumption of citrus 
fruits < 2 times per week [HR (95% CI)=1.36 (1.14-1.63), P-trend <0.001]. The positive 
association was strongest between grapefruit consumption and melanoma risk [≥ 3 times per 
week vs. never, HR (95% CI)=1.41 (1.10-1.82)]; the association was significant but weaker 
between orange juice consumption and melanoma risk [≥ once per week vs. < once per week, 
HR (95% CI)=1.25(1.07-1.47)]. Consumption of grapefruit juice and oranges was generally not 
associated with melanoma risk. This may be because psoralens and furocoumarins are more 
abundant in grapefruit than in grapefruit juice, and the much more prevalent consumption of 
orange juice compared with oranges themselves would counterbalance the lower levels of 
psoralens and furocoumarins in orange juice (5). However, conflicting findings were reported by 
one hospital-based case-control study in Italy (304 cases vs. 305 controls); that study found that 
high citrus consumption seemed to have a beneficial effect against melanoma risk [≥ 5 times per 
week vs. ≤ 2 times per week, OR (95% CI)=0.51(0.32-0.80)] (27).   
Citrus products are widely consumed foods that are rich in psoralens and furocoumarins. 
The mechanism underlying the association between consumption of citrus and the development 
of melanoma could be based on the presence of psoralens and furocoumarins in citrus fruits, 
particularly grapefruit. Photochemotherapy using oral psoralen (methoxsalen) and ultraviolet 
(UV) A radiation (PUVA) is a highly effective therapy for severe psoriasis: psoralen is taken 
orally to sensitize the skin before UVA light treatment. Both epidemiological and experimental 
studies suggested that long-term PUVA therapy increases the risk of melanoma (28,29). 
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light to stimulate proliferation of melanoma cells (30).  
Generally, evidence regarding the association between dietary consumption of psoralen-
rich foods and melanoma risk remains inconclusive. Considering that citrus fruits are widely 
consumed and that their consumption has long been advocated for its potential benefits in 
reducing risk of disorders such as coronary heart disease, additional investigations are needed to 
confirm current findings before making further dietary suggestions to the public (31).  
3. Alcohol
It has been suggested that alcohol intake increases sunburn severity, a major risk factor 
for melanoma skin cancer. In 1977 Williams and Horm first reported a positive association 
between alcohol consumption and risk of melanoma based on Third National Cancer Survey data 
(32). Since then, several epidemiological studies have investigated the relationship between 
alcohol consumption and melanoma, but the evidence is inconsistent (12,33-37).  
A case-control study in Montreal (107 cases vs. 507 controls) found no significant 
association between lifetime consumption of alcoholic beverages and melanoma risk [≥ 7 
drinks/week vs. never, OR (95%CI)=1.21(0.68-2.18)] (33). Similarly, a case-control study in 
Italy (542 cases vs. 538 controls) also failed to find any association [≥ 28 drinks/week vs. never, 
OR (95% CI)=0.83 (0.49-1.40)] (12). On the other hand, high alcohol consumption was 
associated with elevated risk of melanoma [alcohol accounts for ≥ 10% of total calories vs. None, 
OR (95% CI)=1.65 (1.09-2.49)] in another case-control study with 502 cases and 565 controls 
(34). Recently, Miura et al. (35) conducted a pooled analysis of eight case-control studies (1886 
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cases vs. 2113 controls) that found a positive association between ever consuming alcohol and 
melanoma risk among women [adjusted pooled OR (95% CI)=1.3 (1.1-1.5)].  
Large cohort studies have consistently associated increased melanoma risk with alcohol 
consumption. Kubo et al. (36) examined the association among 59,575 white postmenopausal 
women in the Women’s Health Initiative (WHI) Observational Study (OS). They noted a 
significant relationship between the amount of alcohol consumed and risk of melanoma [7+ 
drinks/week vs. nondrinkers, HR (95% CI)=1.64 (1.09-2.49)] after 10.2 means years of follow-
up; compared to nondrinkers, those who consumed either white wine or liquor were at increased 
melanoma risk [white wine: HR (95% CI)=1.52 (1.02-2.27); Liquor: HR (95% CI)= 1.65 (1.07-
2.55)] (36). 
Rivera et al. (37) then examined the association in the NHS (1984-2012), NHS II (1991-
2011), and HPFS (1986-2012) cohorts; they found that higher alcohol intake was associated with 
elevated invasive melanoma risk [pooled multivariate HR (95% CI)=1.14 (1.00–1.29)] per 
drink/day; P-trend < 0.04] over 18.3 means years of follow-up. Similar to findings from the WHI 
(36), white wine consumption was also associated with an increased risk of melanoma in NHS, 
NHS II, and HPFS, after adjusting for other alcoholic beverages [pooled multivariate HR (95% 
CI)=1.13 (1.04-1.24) per drink/ day; P-trend <0.01]. Moreover, Rivera et al. (37) found that the 
association between alcohol consumption and melanoma risk was stronger for melanoma in 
relatively UV-spared sites (trunk) versus more UV-exposed sites (head, neck, or extremities). As 
evidence suggests that etiologies of melanoma differ by anatomic site (25), the authors (37) 
explained the finding by positing that alcohol consumption may affect those etiologic pathways 
differently; alcohol’s carcinogenic effect may be more relevant to melanomas at relatively UV-
spared sites. Similarly, in the previously discussed pooled analysis of eight case-control studies, 
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the positive association between alcohol intake and melanoma was also found to be slightly 
stronger with melanomas on the trunk compared with other body sites (35).  
Finally, one meta-analysis of 14 case-control and 2 cohort studies encompassing a total of 
6251 cases of melanoma showed that alcohol consumption was positively associated with the 
risk of melanoma [any alcohol drinking vs. no/occasional drinking, RR (95% CI)= 1.20 (1.06-
1.37)]. The association was attenuated but remained marginally significant when only the 10 
studies that adjusted for sun exposure were included [any alcohol drinking vs. no/occasional 
drinking, RR (95% CI)= 1.15 (0.94-1.41)] (38).  
Generally, alcohol causes carcinogenesis via acetaldehyde by creating DNA adducts. 
Alcohol may also act as a photosensitizer, and the combination of UV radiation and alcohol 
consumption may potentiate skin carcinogenesis (39). Specifically, ethanol is converted to 
acetaldehyde soon after its ingestion; the metabolite may act as a photosensitizer, generating 
reactive oxygen species and related intermediates, which may further induce oxidative DNA 
damage, enhance the binding of acetaldehyde to DNA, and activate signal-transduction cascades 
and prostaglandin synthesis (39). However, the potential synergistic effect between UV radiation 
and alcohol on skin carcinogenesis needs further exploration, as stronger associations were 
detected between alcohol consumption and melanoma on UV-spared body locations in cohort 
studies (35,37). In addition, epidemiological evidence consistently showed that among all 
alcoholic beverages (36,37), white wine has the strongest association with increased melanoma 
risk. This may because of the far-higher levels of pre-existing acetaldehyde in wine than in beer 
or spirits. In some cases, the pre-existing acetaldehyde alone exceeds carcinogenic levels (40). 
4. Niacin/Nicotinamide
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Niacin, also known as nicotinic acid or vitamin B3, together with its water-soluble amide 
form nicotinamide, makes up the group called vitamin B3 complex. Both niacin and 
nicotinamide are widely available in plant and animal foods; breakfast cereal, multivitamins, and 
B vitamin supplements often contain nicotinamide as niacin (41). 
Nicotinamide is the primary precursor of nicotinamide adenine dinucleotide (NAD+), an 
essential coenzyme in ATP production. Increased skin sensitivity to sun exposure is a well-
known symptom of severe niacin deficiency (pellagra) in humans, which is related to low 
nicotinamide-adenine dinucleotide (NAD) status and deficiencies in responding to UV damage 
(42). Niacin and nicotinamide have been shown to reduce UV-induced immunosuppression (a 
risk factor for skin cancer) in mice and humans when used topically or orally (43). Nicotinamide 
may also have a beneficial protective role against DNA damage and mutagenesis through 
facilitating DNA repair (44). 
However, few epidemiological studies have investigated the association between niacin 
intake and melanoma risk. Recently, Park et al. (45) prospectively evaluated whether total, 
dietary, or supplemental niacin intake was associated with skin cancer risk among 72,308 women 
in the NHS (1984-2010) and 41,808 men in the HPFS (1986-2010). They found the association 
between total niacin intake and melanoma was not statistically significant [top vs. bottom 
quintiles, adjusted-pooled HR (95% CI)=1.18 (0.77-1.81); P-trend=0.07]. Still, higher total 
niacin intake was marginally and positively associated with melanoma risk in men [top vs. 
bottom quintiles, adjusted-pooled HR (95% CI)=1.48 (1.07-2.05); P-trend=0.05], but not in 
women [top vs. bottom quintiles, adjusted-pooled HR (95% CI)=0.96 (0.73-1.27); P-trend=0.67] 
(45). More epidemiological studies are needed to evaluate the effect of niacin intake on skin 
cancer risk. 
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5. Polyunsaturated fatty acid
Omega-6 (n-6) and omega-3 (n-3) polyunsaturated fatty acids (PUFAs) are both essential 
for human health. PUFAs are important structural components of membrane phospholipids and 
precursors of families of signaling molecules (e.g., eicosanoids). Eicosanoids derived from 
omega-6 (n-6) and omega-3 (n-3) PUFAs are functionally distinct; some even have important but 
opposing physiological functions (46).  
The beneficial impact of long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFAs) on 
human health have been widely observed and primarily attributed to the two LC n-3 PUFAs, i.e., 
eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3) (47). EPA 
and DHA are abundant in fish and other seafood. The possible antineoplastic effect of dietary LC 
n-3 PUFAs has been supported by many basic science studies that have identified a number of
molecular factors and pathways involved in cell growth, apoptosis, invasion, and angiogenesis 
and are affected by these fatty acids (48). Recent evidence regarding the potential of LC n-3 
PUFAs to abrogate photo-immunosuppression in human skin has provided additional support for 
their chemopreventive role against skin cancers (49). Direct evidence from animal studies has 
shown that n-3 PUFAs inhibit UV-induced carcinogenesis (50). Additionally, emerging evidence 
suggests that it is actually the n-6/n-3 fatty acid ratio, rather than the absolute levels of the two 
classes of PUFAs, that plays the principal role in the antitumor effects of n-3 PUFAs (46). 
Though the biological plausibility of the antitumor effect of n-3 PUFAs has been well 
established through preclinical research, epidemiological evidence to date regarding melanoma 
remains both limited and inconsistent. Early case-control studies showed no association between 
PUFA-rich food consumption and melanoma risk (51,52). The beneficial effect was suggested by 
an epidemiological study that showed relatively low rates (estimated by standardized incidence 
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ratios) of melanoma in the Inuit, an Eskimo population whose fish-based diet results in a high 
daily intake of LC n-3 PUFAs compared to rates in Connecticut, Denmark, and Canada (53). 
One hospital-based case-control study in Italy (304 incident melanoma cases and 305 controls) 
showed an inverse association between consumption of fish rich in n-3 fatty acids and melanoma 
risk [low vs. high intake, OR (95% CI)=0.52 (0.34-0.78)] (27). However, actual PUFA intakes 
were not calculated based on food frequency questionnaire (FFQ), nor were serum PUFA levels 
tested (27,51-53). Bain et al. (54) conducted a population-based case-control study of 41 women 
with melanoma and 297 controls from the same community (Brisbane, Australia). Diet was 
assessed by a comprehensive FFQ. Results indicated a strong inverse relation between high 
intakes of polyunsaturated fatty acids and melanoma (P < 0.01). Recently, Donat-Vargas et al. 
(55) examined the association between dietary EPA-DHA intake (FFQ based) and melanoma
risk using data from the Swedish Mammography Cohort (follow up: 4.5 years); they found that 
higher dietary EPA-DHA intake was significantly associated with lower melanoma risk [highest 
vs. lowest tertiles, HR (95% CI)=0.2 (0.1-0.8), P-trend=0.03]. Results from Nurses’ Health 
Study (NHS, 1984-2012) and the Health Professionals Follow-up Study (HPFS, 1986-2012) 
showed that higher n-6 PUFA intake was associated with an increased risk of melanoma (highest 
vs. lowest quintiles, HR (95% CI)=1.20 (1.02-1.41), P-trend=0.03); no other fats were 
significantly associated with melanoma risk (56).  
Taken together, observational studies published to date have not clearly explained the 
role of PUFAs in the development of melanoma. Recently, to explore the causal link of PUFA 
levels and melanoma risk, Liyanage et al. conducted a mendelian randomization analysis using 
12,874 cases and 23,203 controls from the largest melanoma genome-wide association study 
(GWAS) meta-analysis; their results showed that the effect of increased PUFA levels on 
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melanoma risk is either zero or very small (57). As observational studies are always subject to 
residual confounding, which makes it difficult to interpret observed findings, further studies are 
needed to explore the causality of PUFAs and melanoma risk.  
It is worth mentioning that, in basic research, animals or cells are treated with purified 
LC n-3 PUFAs. However, PUFA intake in most epidemiological studies is evaluated based on 
the amounts/frequency of fish ingested. This information is usually obtained through FFQ, in 
which the actual levels of different types of PUFAs (n-3/n-6) and consumption of different types 
of fish are difficult to estimate. Some fish (e.g., lean fish) actually contain very low levels of LC 
n-3 PUFAs. In addition, subjects considered “high consumers” in one region might be described
as “low consumers” in other regions, causing further confusion in the interpretation of results. 
However, few epidemiological studies published to date have examined the associations between 
biomarkers such as erythrocyte or serum levels of LC n-3 PUFA with melanoma risk. Therefore, 
studies applying both biomarkers and FFQ would be needed to better explore the relationships 
between fatty acids and the risk of cancers in population groups (48).  
6. Folate/folic acid
Folate (vitamin B9), along with vitamins B2, B12, and B6 are the sources of coenzymes 
participating in the one-carbon metabolism (58). Folic acid is a synthetic form of folate. Due to 
the confirmed protective effect of folate against neural tube defects (59), folic acid 
supplementation is now recommended for women during the periconceptional period, and 
nationwide folate fortification of flour has been mandatory in US (60) and Canada (61) for 
around two decades. However, folate fortification is still not mandatory in many European, 
Asian, and African countries (62). One of the biggest concerns for adults is the potential elevated 
cancer risk related to folate intake.  
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Epidemiological evidence regarding the relationship between folate and overall/site-
specific cancer risk is quite inconsistent; positive, inverse, as well as null associations have all 
been reported (63-66). Recently, increased risks of overall skin cancer [third vs. first tertiles: HR 
(95% CI)= 1.79 (1.07-2.99)] associated with dietary folate intake were reported in a prospective 
cohort study (follow-up: 1994-2007) in France (67). In terms of folate intake and melanoma risk, 
epidemiological studies are limited. One meta-analysis of randomized controlled trials showed 
no significant effect of folic acid supplementation on the risk of melanoma skin cancer (63). 
However, an inverse association between folic acid supplementation and melanoma risk was 
found by another meta-analysis of three trials [RR (95% CI)=0.47 (0.23-0.94)] (64). There were 
no any published prospective cohort analyses specifically examining the relationship between 
dietary folate/folic acid and melanoma. 
Some animal studies have suggested that folate might have a dual effect on cancer, i.e., 
high folate intakes could suppress the development of early lesions in normal tissue (i.e., protect 
against cancer initiation) but facilitate the growth of pre-neoplastic cells and subclinical 
neoplasms (68). Research has also shown that folic acid is associated with cellular phototoxicity 
and photogenotoxicity (69); this finding could provide further clues in explaining the relationship 
between folate and skin cancer risk. 
7. Vitamin D
Vitamin D has long been known to be essential for human bone health. Ultraviolet 
radiation (UVR) exposure, diet, and supplements are the sources of Vitamin D, of which UVR is 
the major source. Emerging evidence suggests that vitamin D also plays an important role in 
reducing the risk of heart disease, autoimmune disease, and cancer, and in supporting cognitive 
function (70). Paradoxically, vitamin D deficiency has been linked to increased melanoma risk 
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and progression with conflicting results, although sun exposure is an established risk factor for 
melanoma (71).  
7.1 Vitamin D intake and melanoma risk 
In vitro research has found that vitamin D has anti-proliferative effects on cultured 
melanoma cells (72). However, epidemiological data supporting the chemopreventive effect of 
vitamin D intake against melanoma remains inconsistent. One U.S. case-control study found that 
higher energy-adjusted vitamin D intake from food was significantly associated with lower 
melanoma risk [highest versus lowest quintiles, OR (95% CI)= 0.61 (0.40-0.95)]; however, the 
association became only marginally significant when combined vitamin D intake from both food 
and supplements was considered [highest versus lowest quintiles, OR (95% CI)= 0.66 (0.42-
1.02)] (34). An inverse association between dietary vitamin D intake and melanoma risk was also 
reported in a population-based case-control study (380 cases vs. 719 controls) in a northern 
region of Italy [highest versus lowest quintiles, OR (95% CI)= 0.53 (0.31-0.88)] (73). 
On the other hand, most cohorts found null results. For example, 10-year follow-up of the 
Vitamins and Lifestyle cohort study, a large prospective US cohort study, found no significant 
difference in melanoma risk among the highest quartiles of dietary vitamin D intake [RR (95% 
CI)=1.31 (0.94-1.82)], supplemental vitamin D intake [RR (95% CI)=1.13 (0.89-1.43)], and 
combined dietary and supplemental intake [RR (95% CI)=1.05 (0.79-1.40)], compared with the 
lowest quartile (74). Also, null associations between total, dietary, and supplemental vitamin D 
intake with melanoma risk were found in cohort analyses based on 63,760 women in the Nurse’s 
Health Study (1984-2010) and 41,530 men in the Health Professionals Follow-up Study (1986-
2010) (75). Finally, post hoc analyses of the Women’s Health Initiative Randomized Controlled 
Trial (mean follow-up: 7 years) found no difference in melanoma incidence between the 
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treatment group (1,000 mg of elemental calcium plus 400 IU of vitamin D3 daily) and the 
placebo group [HR (95% CI)=0.86 (0.64-1.16)]; however, subgroup analysis showed a beneficial 
role of vitamin D supplementation against melanoma risk among women with a history of 
NMSC [HR (95% CI)=0.43 (0.21-0.90)] (76). 
7.2 Serum vitamin D level and melanoma risk/survival 
Serum 25-hydroxyvitamin D [25(OH)D] level is a general reflection of vitamin D stored 
in the human body and obtained from UV exposure, diet, and supplements. Newton-Bishop et al. 
(77) reported an inverse relationship between serum vitamin D levels and melanoma risk in a
case-control study in the UK [OR (95% CI)=0.64 (0.46-0.87) per 20 nmol/L increase across 
seasons]. The associations between insufficient and deficient serum levels of vitamin D and 
melanoma risk were also reported by a recent case-control study in Italy (137 cases vs. 99 
controls) (78). Meta-analysis of four studies including 392 melanoma cases did not indicate a 
significant association between 25(OH)D serum levels and melanoma risk [highest vs. lowest, 
RR (95% CI)=1.46 (0.60-3.53)] (79). However, a marginally significant and positive association 
was found between melanoma and serum 25(OH) D level in an 11-year prospective study in 
Australia [OR (95% CI)=2.71 (0.98-7.48) for 25(OH)D level ≥ 75 vs. <75 nmol/L, OR (95% 
CI)=2.70 (0.83-8.77) for every 50 nmol/L increase in 25(OH)D concentration] (80). A 
prospective cohort study of 10,060 Danish participants also found that increasing levels of 
plasma 25(OH)D were associated with elevated risk of melanoma after 28 years’ follow-up [HR 
(95% CI)=4.72 (0.96-23.3) for 25(OH) D level ≥ 50 vs. <25 nmol/L, HR (95% CI)=9.58 (2.37-
38.7) for 25(OH) D level ≥ 100 vs. <25 nmol/L] (81). The positive association between serum 
vitamin D level and melanoma risk may be because serum vitamin D levels are strongly 
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associated with increased sun exposure, and thus may simply act as a surrogate for excess sun 
exposure (77).  
Existing epidemiological evidence indicates that serum vitamin D levels are also related 
to melanoma outcomes. Gambichler et al. reported that lower serum 25(OH)D levels are 
associated with greater tumor thickness and more-advanced tumor stage in a German cohort of 
764 patients with melanoma (82). In the Leeds Melanoma Cohort of 872 melanoma patients, 
Newton-Bishop et al. found that higher 25-hydroxyvitamin D3 levels were significantly 
associated with lower Breslow thickness at diagnosis and better survival [For relapse-free 
survival, HR (95% CI) = 0.79 (0.64-0.96) for a 20 nmol/L increase in serum vitamin D level], 
after a median follow-up of 4.7 years (83). Saiag et al. found that in melanoma patients, 
25(OH)D3 levels at diagnosis were inversely correlated with prognostic factors including 
ulceration, cancer staging, and Breslow’s thickness, but not with risk of relapse; however, 
changes in 25(OH)D3 levels in both directions during follow-up were associated with worse 
prognosis (84). Recently, a retrospective pilot study also found that high serum vitamin D level 
was correlated with better prognostic indicators among patients diagnosed with primary 
melanoma (85). Taken together, those lines of evidence suggest that correction of low vitamin D 
levels after diagnosis may be beneficial for melanoma-specific survival; however, the findings of 
observational studies need to be confirmed in randomized controlled trials, and additional studies 
are needed to establish optimal serum levels for melanoma patients.  
Conclusion and Future directions 
In conclusion, major epidemiological evidence so far suggests that caffeine intake may 
have beneficial protective effects against cutaneous malignant melanoma, while citrus fruits and 
alcohol consumption may play detrimental roles. Though experimental studies have suggested 
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biological mechanisms for these links, few conclusions are possible based on data from RCTs 
supporting the efficacy of dietary modification for the prevention of melanoma. Findings 
regarding the associations between polyunsaturated fatty acid, niacin/nicotinamide, folate intakes, 
and Vitamin D with melanoma are still quite inconsistent. These associations require additional 
explorations through prospective studies. Noteworthily, observational studies are subject to 
limitations such as residual confounding and reverse causality. In addition, the assessment of diet 
intakes based on food frequency questionnaire may result in recall bias in case-control studies. 
These points may somewhat help explain the inconsistent results observed in cohort and case-
control studies regarding certain associations. Therefore, more randomized trials are needed to 
confirm the results from observational studies. Moreover, development of more-robust dietary 
biomarkers using high-throughput technologies would be highly recommended. For dietary 
factors with potential beneficial impact, further efforts are needed to identify the main molecular 
targets in melanoma. Additionally, the role of gene-diet interaction in melanoma development 
could also be explored. These efforts are crucial for understanding the underlying mechanism 
and developing precision chemoprevention strategies for melanoma.  
In addition, emerging data has suggested that a combination of nutrients and foods may 
demonstrate stronger associations with cancer risk compared with specific nutrients or food types; 
healthy dietary patterns have been associated with lower risk of cancers including pancreatic, 
colorectal and breast cancer (86,87). However, to date, few epidemiological studies have 
examined dietary patterns and melanoma risk. Fortes et al. found the Mediterranean diet may 
have protective effects against melanoma (27). Malagoli et al. found an inverse association 
between melanoma risk with the Healthy Eating Index 2010 (HEI-2010) and Dietary Approaches 
to Stop Hypertension (DASH) index, which both assess diet quality (88). These lines of evidence 
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suggested that dietary patterns could affect risk of melanoma. Therefore, more epidemiological 
studies investigating possible associations between dietary pattern and melanoma risk should be 
encouraged, since they are crucial before incorporating dietary interventions into clinical and 
nutritional practice.  
Given the high prevalence of food items and nutrients covered in this review, along with 
rising melanoma incidence over recent decades worldwide, the associations we discuss may have 
important public health implication, and may eventually be useful for the prevention of 
cutaneous malignant melanoma. 
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